The FP7 project MITIGATE will develop a closed-loop molecular environment for minimally invasive treatment of patients with metastatic Gastrointestinal Stromal Tumours (GIST).

The MITIGATE consortium representing three European universities, three research organisations and four SMEs will pursue the ultimate goal to develop new protocols and guidelines to effectively diagnose and treat patients with metastatic GIST resistant to current treatment.
MITIGATE developed novel procedures for the analysis of tissues and biofluids based on mass spectrometry. For diagnostic purposes, analysis services for processing biofluid samples (like blood or urine) and tissue samples from biopsies or resections can be offered.

Based on mass spectrometry measurements, molecular information of the sample is acquired which can be used for a detailed characterisation of the tissue or biofluid. For example, information about metastasis mutation and even prediction of response to medication. In contrast to existing technologies, mass spectrometry measurements are not specific to a single target. This technique can be used to support the diagnosis and therapy of a broad range of diseases.
GOAL OF THIS SURVEY

The goal of this short survey (5 minutes) is to assess the end-user community and their interest in the products developed by MITIGATE.

Question Title

* 1. Where are you working?

Question Title

* 2. How many tissue diagnoses are performed at your institution per week?

Question Title

* 3. How many biofluid diagnoses are performed at your institution per week?

Question Title

* 4. What is your institution’s average handling time for standard tissue diagnostic tasks (without sample acquisition)?

Question Title

* 5. What is your institution’s average handling time for standard biofluid diagnostic tasks (without sample acquisition)?

Question Title

* 6. What is the average price for tissue diagnoses?

Question Title

* 7. What is the average price for biofluid diagnoses?

Question Title

* 8. Would you be interested in an external service provider for tissue or biofluid diagnostics?

Question Title

* 9. If yes, what would you pay for such a service?

Question Title

* 10. If you are interested in learning more about the MITIGATE project and would like to receive our annual newsletter, please enter your contact details below.

Question Title

* 11. Do you have any general comments or remarks?

( Privacy & Cookie Notice

T